Paper Details

  1. Home
  2. Paper Details

Striving for euthyroidism in radioiodine therapy of Graves' disease: a 12-year prospective, randomized, open-label blinded end point study.

Author: ChenDan Yun, ChenTang Hua, HeZhi Min, JingJin, SchneiderPeter F, ZhangXiang Song

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study investigates optimal dosing strategies for (131)I treatment of hyperthyroidism due to Graves' disease (GD) in China, aiming to achieve euthyroidism and minimize the need for long-term levothyroxine treatment.
Paper Details　
Original Abstract of the Article :
In China, use of radioiodine therapy is problematic because of the need for lifelong levothyroxine substitution. Our aim was to find an optimum dosing strategy for (131)I treatment of hyperthyroidism due to Graves' disease (GD). We attempted to achieve euthyroidism to avoid long-term levothyroxine t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1089/thy.2010.0348

データ提供：米国国立医学図書館（NLM）

Striving for Euthyroidism in Radioiodine Therapy of Graves' Disease

[Graves' disease] is an autoimmune disorder that affects the thyroid gland. [Radioiodine therapy] is a common treatment for hyperthyroidism due to Graves' disease. This study investigated the optimal dosing strategy for radioiodine therapy to achieve [euthyroidism] and potentially avoid long-term levothyroxine treatment.

Finding the Right Dose

This study is like a camel caravan searching for a hidden oasis - the perfect dose of radioiodine therapy for Graves' disease. The researchers sought to find the optimal dosing strategy to achieve euthyroidism, minimizing the need for long-term medication. This study offers valuable insights into the challenges of treating Graves' disease and the ongoing search for effective and personalized treatment approaches.

Dr. Camel's Conclusion

This research is a testament to the ongoing quest for better treatment strategies for Graves' disease. By carefully considering the optimal dosing of radioiodine therapy, we can help individuals navigate the desert of thyroid dysfunction and achieve a state of well-being.
Date :
  1. Date Completed 2011-09-26
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

21563916

DOI: Digital Object Identifier

10.1089/thy.2010.0348

Related Literature

Article Analysis
・Effective treatment of hyperthyroidism
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.